Genencor International to Present at the BIO CEO & Investor Conference

Genencor International to Present at the BIO CEO & Investor
Conference 


PALO ALTO, Calif., Feb. 17  /PRNewswire-FirstCall/ -- Genencor International,
Inc. (NASDAQ:GCOR) today announced that the company will present at the BIO CEO
& Investor Conference at 2:00 p.m. EST on Wednesday, February 23, 2005 at the
Waldorf Astoria Hotel in New York, New York. Jean-Jacques Bienaime, Genencor's
chairman, chief executive officer and president will provide an overview of the
company.

The live audio webcast of the presentation as well as the replay will be
available at
http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=GCOR&item_id=1009152
and the slide presentation may be accessed on the homepage at
http://www.genencor.com/.

About Genencor

Genencor International is a diversified biotechnology company that develops and
delivers innovative products and services into the health care,
agri-processing, industrial and consumer markets. Using an integrated set of
technology platforms, Genencor's products deliver innovative and sustainable
solutions to many of the problems of everyday life.

Genencor traces its history to 1982 and has grown to become a leading
biotechnology company, with over $410 million in year 2004 annual revenues.
Genencor has principal offices in Palo Alto, California; Rochester, New York;
and Leiden, the Netherlands. 

DATASOURCE: Genencor International, Inc.



CONTACT:  media, Valerie Tucker, [phone], or investors,

Thomas Rathjen, [phone], both of Genencor International, Inc.



Web site:  http://www.genencor.com/ 

Copyright